rosiglitazone has been researched along with 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chien, S; Forman, BM; Formentin, K; Lee, TS; Liu, Y; Rannou, F; Shyy, JY; Wang, N; Yuan, X; Zeng, L; Zhu, Y | 1 |
1 other study(ies) available for rosiglitazone and 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one
Article | Year |
---|---|
Laminar flow activates peroxisome proliferator-activated receptor-gamma in vascular endothelial cells.
Topics: Animals; Cattle; CD36 Antigens; Cells, Cultured; Chlorocebus aethiops; Cytochrome P-450 Enzyme System; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Humans; Inflammation; Naphthalenes; NF-kappa B; Phospholipases A; Phospholipases A2; PPAR gamma; Pyrones; Reverse Transcriptase Polymerase Chain Reaction; Rheology; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Stress, Mechanical; Thiazolidinediones; Transcription, Genetic; Transfection | 2004 |